Boston-based startup Cerevasc Inc. scooped up $43.9 million in a series A round that was led by Perceptive Xontogeny Venture (PXV) Fund and Aton Partners LLC. The funds are earmarked to support a first-in-human trial of the company’s Eshunt system for the treatment of hydrocephalus, as well as subsequent clinical studies to support regulatory approvals. Read More
Researchers at New York-based Feinstein Institutes for Medical Research, the research arm of Northwell Health, showed that anodal block can be used for directional vagus nerve stimulation (VNS) in a new paper in Scientific Reports. Read More
Rear Admiral John Polowczyk, vice director of logistics for the Joint Chiefs of Staff, said in a Senate hearing that the one solution to managing pandemic supplies might be to use federal taxpayer dollars to sustain inventories in private-sector warehouses. Read More
A long-term clinical trial comparing minimally invasive cryoablation to surgery to treat early stage kidney cancer patients has found that the former offers comparable rates of survival and fewer complications. Johns Hopkins researchers published the 10-year survival data for 134 patients in the June 9, 2020, issue of Radiology. Read More
TORONTO – Vancouver, B.C.-based Sonic Incytes Medical Corp. is giving MRI a run for its money assessing chronic liver disease following a successful, CA$3.5 (US$2.6 million) seed round. That brings total funding to CA$8 million (US$5.92 million) for a hand-held ultrasound device that quantifies liver disease using 3D tissue sampling and analysis in approximately five minutes in a doctor’s office. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agios Pharmaceuticals, Applied DNA Sciences, Biosensors International, Blue Sail Medical, Cepheid, Cytosorbents, Endovantage, Gene-IQ, Isoplexis, Makemedical, Mallinckrodt, Naglreiter Consulting, Nvt, RapidAI, Thermo Fisher, Titan Medical, Veracyte, Xoran Technologies. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: 4web Medical, Atomic Blue, Dexcom, Hangzhou Biotest Biotech, Incelldx, Seasun Biomaterials, Sekisui Diagnostics, Vasoptic Medical. Read More
Keeping you up to date on recent developments in oncology, including: Hydrogen peroxide stimulates gold nanorods, paclitaxel, for cancer treatment; Oncometabolites mask DNA repair signals; Stress-induced mutagenesis leads to cancer drug resistance; Nanomotoring in bladder cancer. Read More
